UPDATE 1-Evotec profit target in danger after drug trial halted
September 08, 2014 at 14:23 PM EDT
BERLIN, Sept 8 (Reuters) - German biotechnology company Evotec may miss its profit target for 2014 after a trial involving a drug for which it expected to receive royalties was halted.
